<unk>  is an monoclonal antibody that is FDA approved for the treatment of unresectable or metastatic melanoma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include pruritus, colitis, fatigue.
Ipilimumab
Pembrolizumab
Bavituximab
Volociximab
Daratumumab
Adecatumumab
Axitinib
Lexatumumab